increased solubility = different PK profile? [Dissolution / BCS / IVIVC]

posted by nobody – 2017-06-08 19:16 (2950 d 07:44 ago) – Posting: # 17462
Views: 15,380

Hi Dr!

To me: That's not how it works with generics. Go for equivalent dissolution and therefore Cmax/AUC. End of story.

Why go for "better" solubility and end up non-BE? ;-) Don't see the point at all.

You could go for some hybrid application in Europe (regulatory is not my piece of cake), but good luck with explaining the "advantage" of your product to the authority(ies) :-D
—
Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,679 registered users;
41 visitors (0 registered, 41 guests [including 11 identified bots]).
Forum time: 03:00 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5